Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Ropivacaine Infusion for Post-TSA Pain
NCT02787226Phase 4Terminated
- Start
- Aug 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain. Started Aug 2014; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02787226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787226.